Castle Biosciences, Inc. · NASDAQ:CSTL

Maetzold Derek J sold 9,002 Castle Biosciences, Inc. shares (Form 4)

Traded Jun 1, 2026 · Filed Jun 3, 2026

On Jun 1, 2026, Maetzold Derek J (Director, Pres. & Chief Exec. Officer) sold 9,002 Castle Biosciences, Inc. shares at US$20.86 for US$188K under a trading plan, leaving 1,668 shares. Filed Jun 3, 2026 (Form 4).

Sold
9,002 shares
Price
US$20.86
Value
US$188K
Holding after
1,668 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Pres. & Chief Exec. Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 1, 2026Common StockOption exercise204US$2.3921,683Direct
Jun 1, 2026Common StockOption exercise6,010US$2.3927,693Direct
Jun 1, 2026Common StockSale6,214US$20.8621,479Direct
Jun 1, 2026Common StockSale1,357US$20.8643,424Indirect
Jun 1, 2026Common StockSale1,153US$20.8636,908Indirect
Jun 1, 2026Common StockSale278US$20.861,668Indirect

Source

View original at SEC

Related